M Penka Selected Research

M Penka Research Topics

Disease

15	Hemorrhage 12/2019 - 03/2006
10	Multiple Myeloma 08/2017 - 01/2002
8	Neoplasms (Cancer) 01/2018 - 03/2006
5	Thrombosis (Thrombus) 06/2013 - 03/2006
4	Hemophilia A (Haemophilia) 11/2012 - 09/2008
4	Thrombocytopenia (Thrombopenia) 06/2012 - 03/2006
3	Venous Thrombosis (Deep-Vein Thrombosis) 12/2019 - 03/2006
3	Disseminated Intravascular Coagulation 06/2012 - 01/2008
3	Venous Thromboembolism 01/2011 - 03/2006
2	Immunoglobulin Light-chain Amyloidosis 08/2017 - 01/2010
2	Monoclonal Gammopathy of Undetermined Significance 08/2017 - 01/2008
2	Neoplasm Metastasis (Metastasis) 04/2017 - 02/2012
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 06/2013 - 05/2006
2	Essential Thrombocythemia 06/2013 - 05/2006
2	Thrombocytosis (Thrombocythemia) 06/2013 - 05/2006
2	Sepsis (Septicemia) 06/2012 - 03/2006
2	Chronic Hepatitis C 09/2005 - 01/2004
1	Hematoma 12/2019
1	Intra-Abdominal Hypertension 12/2019
1	Disease Progression 01/2018
1	Amyloidosis 08/2017
1	Paraproteinemias (Monoclonal Gammopathy) 08/2017
1	Amyloid Plaque 08/2017
1	Primary Myelofibrosis (Myelosclerosis) 06/2013
1	Acute Pain 11/2012
1	Hemolysis 06/2012
1	Inflammation (Inflammations) 06/2012
1	Multiple Organ Failure (MODS) 06/2012
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 06/2012
1	Liver Diseases (Liver Disease) 03/2011
1	Leukemia 02/2011
1	Portal Hypertension 02/2011
1	Splenomegaly 02/2011
1	Colorectal Neoplasms (Colorectal Cancer) 01/2011
1	Factor X Deficiency 01/2010
1	Mucositis 01/2010
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 03/2009
1	Drug-Related Side Effects and Adverse Reactions 07/2008
1	Blood Coagulation Disorders 06/2008
1	Burns 01/2008
1	Wounds and Injuries (Trauma) 01/2008

Drug/Important Bio-Agent (IBA)

4	AnticoagulantsIBA 04/2017 - 03/2006
3	recombinant FVIIa (rFVIIa)FDA Link 08/2010 - 09/2008
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2006 - 03/2006
3	Heparin (Liquaemin)FDA LinkGeneric 03/2006 - 03/2006
2	Biomarkers (Surrogate Marker)IBA 08/2017 - 08/2017
2	anagrelide (Agrylin)FDA LinkGeneric 06/2013 - 05/2006
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2013 - 01/2011
2	Factor VIIa (Activated Factor VII)IBA 11/2012 - 05/2009
2	Plasminogen Activator Inhibitor 1IBA 06/2012 - 01/2011
2	CytokinesIBA 06/2012 - 01/2010
2	Dacarbazine (DIC)FDA LinkGeneric 03/2011 - 01/2008
2	AntigensIBA 01/2010 - 01/2008
2	Warfarin (Coumadin)FDA LinkGeneric 03/2009 - 03/2006
2	Antiphospholipid AntibodiesIBA 03/2009 - 03/2006
2	Fondaparinux (Arixtra)FDA Link 03/2006 - 03/2006
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2018
1	MicroRNAs (MicroRNA)IBA 08/2017
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 08/2017
1	Circulating MicroRNAIBA 08/2017
1	Amyloid (Amyloid Fibrils)IBA 08/2017
1	altersolanol AIBA 04/2017
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 06/2013
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 06/2012
1	Blood Coagulation Factors (Coagulation Factor)IBA 06/2012
1	AntithrombinsIBA 06/2012
1	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2012
1	Protein CIBA 06/2012
1	Endothelial Protein C ReceptorIBA 06/2012
1	Thromboplastin (Tissue Factor)IBA 06/2012
1	ThrombomodulinIBA 06/2012
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2012
1	Hemoglobins (Hemoglobin)IBA 02/2011
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2010
1	Factor X (Stuart Factor)IBA 01/2010
1	Vincristine (Oncovin)FDA LinkGeneric 01/2010
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2010
1	Factor VIII (Coagulation Factor VIII)IBA 05/2009
1	anti-inhibitor coagulant complexIBA 05/2009
1	Immunoglobulins (Immunoglobulin)IBA 01/2009
1	VaccinesIBA 01/2009

Therapy/Procedure

16	Therapeutics 12/2019 - 09/2001
2	Autologous Transplantation 01/2010 - 01/2007
2	Drug Therapy (Chemotherapy) 01/2010 - 01/2010
1	Conservative Treatment 12/2019
1	Central Venous Catheters 04/2017
1	Glycemic Control 06/2012
1	Stem Cell Transplantation 02/2011
1	Contraindications 02/2011
1	Induction Chemotherapy 01/2011
1	Microspheres (Microsphere) 09/2010
1	Off-Label Use 08/2010
1	Immunotherapy 01/2010
1	Erythrocyte Transfusion 01/2010
1	Injections 05/2009
1	Time-to-Treatment 05/2009
1	Anticoagulation Reversal 03/2009
1	Oral Administration 03/2006